NCT06412965View on ClinicalTrials.gov

Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine

CompletedOBSERVATIONAL

Enrollment

528

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

January 3, 2024

Study Completion Date

January 3, 2024

Conditions

Migraine Disorders

Trial Locations (1)

10001

Pfizer, New York

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY